Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario

This patient case is fictional and does not represent events or a response from an actual patient. The authors developed this fictional case for educational purposes only. Brady, a 54-year-old white male, was diagnosed with metastatic renal cell carcinoma (mRCC). Two and a half years prior, he had u...

Descripción completa

Detalles Bibliográficos
Autores principales: Allman, Kimberly D., Ryan, Joanne C., Clair, Andrew, Yenser-Wood, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Grand Rounds
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779571/
https://www.ncbi.nlm.nih.gov/pubmed/33457061
http://dx.doi.org/10.6004/jadpro.2019.10.5.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779571/
https://www.ncbi.nlm.nih.gov/pubmed/33457061
http://dx.doi.org/10.6004/jadpro.2019.10.5.6

Ejemplares similares